S&P Futures
4,072.75 -12.00 (-0.29%) Dow Futures
32,520.00 -61.00 (-0.19%) Nasdaq Futures
12,498.25 -62.00 (-0.49%) Russell 2000 Futures
1,831.00 -6.20 (-0.34%) Crude Oil
113.17 +0.77 (+0.69%) Gold
1,807.40 -11.50 (-0.63%)
Esperion Therapeutics, Inc. (ESPR)
After hours:
Chart Events
Performance Outlook
| Previous Close | 5.89 |
| Open | 5.97 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1300 |
| Day's Range | 5.90 - 6.56 |
| 52 Week Range | 3.28 - 26.77 |
| Volume | |
| Avg. Volume | 1,431,983 |
| Market Cap | 406.294M |
| Beta (5Y Monthly) | 0.65 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -11.69 |
| Earnings Date | May 02, 2022 - May 06, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.85 |
- GlobeNewswire
Esperion to Participate in Upcoming H.C. Wainwright Global Investment Conference
ANN ARBOR, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced that President and Chief Executive Officer, Sheldon Koenig, will participate in a fireside chat at the upcoming H.C. Wainwright Global Investment Conference on Tuesday, May 24th, 2022. Event:H.C. Wainwright Global Investment ConferenceDate:Tuesday, May 24th, 2022Format:Presentation and 1:1 MeetingsTime:7:00 am Eastern Standard TimeWebcast:Link A live audio webcast can be accessed on the investor and media
- Simply Wall St.
Esperion Therapeutics, Inc. (NASDAQ:ESPR): Are Analysts Optimistic?
Esperion Therapeutics, Inc. ( NASDAQ:ESPR ) is possibly approaching a major achievement in its business, so we would...
- Zacks
Esperion (ESPR) Q1 Earnings Beat on Robust Demand for Drugs
Esperion Therapeutics (ESPR) reports solid first-quarter results, beating estimates for earnings and sales. Cost-savings programs boost margins. Stock rallies.
